World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
42
Citations
7209
World Ranking
17467
National Ranking
4280

Keykavous Parang publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Keykavous Parang sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 253 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Keykavous Parang D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Keykavous Parang sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 42 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Keykavous Parang is affiliated with Chapman University in the United States and has a research profile focused on biochemistry, genetics, and molecular biology, with significant contributions to medicine. Their scholarly work spans multiple subfields including molecular biology, organic chemistry, microbiology, oncology, and infectious diseases.

The researcher's work addresses several specialized topics, notably RNA interference and gene delivery, antimicrobial peptides and activities, advanced biosensing and bioanalysis techniques, chemical synthesis and analysis, click chemistry and applications, microRNA in disease regulation, and antimicrobial agents and applications.

Keykavous Parang has published extensively in various scientific journals. The frequent publication venues include:

  • Molecules
  • Preprints.org
  • Pharmaceutics
  • Journal of Medicinal Chemistry
  • Pharmaceuticals

Some of the recent papers authored or coauthored by Keykavous Parang are:

  • "A Global Review on Short Peptides: Frontiers and Perspectives," 2021, Molecules
  • "Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold," 2021, Biomolecules
  • "Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration," 2021, Proceedings of the National Academy of Sciences
  • "Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)," 2020, Molecules
  • "Membrane-Active Cyclic Amphiphilic Peptides: Broad-Spectrum Antibacterial Activity Alone and in Combination with Antibiotics," 2022, Journal of Medicinal Chemistry

Keykavous Parang frequently collaborates with other researchers in the field. The principal coauthors include:

  • Rakesh Kumar Tiwari
  • Sandeep Lohan
  • Eman H. M. Mohammed
  • Saghar Mozaffari
  • Dindyal Mandal

Their research contributions demonstrate ongoing involvement in both fundamental and applied aspects of molecular biology and medicinal chemistry. The combination of work on peptides, nucleic acids, and bioactive molecules reflects a multidisciplinary approach aimed at addressing issues related to infectious diseases, cancer, and biochemical mechanisms.

Best Publications

  • Self-assembly of peptides to nanostructures

    Dindyal Mandal;Amir Nasrolahi Shirazi;Keykavous Parang

  • Mechanism-based design of a protein kinase inhibitor.

    Keykavous Parang;Jeffrey H. Till;Ararat J. Ablooglu;Ronald A. Kohanski

  • Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event.

    Rashna Bhandari;Adolfo Saiardi;Yousef Ahmadibeni;Adele M. Snowman

  • Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters.

    Deendayal Mandal;Amir Nasrolahi Shirazi;Keykavous Parang

  • Novel Approaches for Designing 5'-O-Ester Prodrugs of 3'-Azido-2'3'-Dideoxythymidine (AZT)

    Keykavous Parang;Leonard I. Wiebe;Edward E. Knaus

  • Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome

    Cong Cao;Mengia S. Rioult-Pedotti;Paolo Migani;Crystal J. Yu

  • Inhibitors of Protein Kinase Signaling Pathways Emerging Therapies for Cardiovascular Disease

    Thomas Force;Keisuke Kuida;Mark Namchuk;Keykavous Parang

  • Current Targets for Anticancer Drug Discovery

    Nguyen Hai Nam;Keykavous Parang

  • Designing bisubstrate analog inhibitors for protein kinases

    Keykavous Parang;Philip A Cole

  • Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.

    Amir Nasrolahi Shirazi;Rakesh Tiwari;Bhupender S. Chhikara;Dindyal Mandal

  • Development of cytarabine prodrugs and delivery systems for leukemia treatment

    Bhupender S Chhikara;Keykavous Parang

  • Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities

    Anil Kumar;Anil Kumar;Israr Ahmad;Bhupender S. Chhikara;Rakesh Tiwari

  • A review (Research and Patents) on jasmonic acid and its derivatives

    Abdollah Ghasemi Pirbalouti;Abdollah Ghasemi Pirbalouti;Seyed Ebrahim Sajjadi;Keykavous Parang

  • Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.

    Bhupender S. Chhikara;Nicole St. Jean;Deendayal Mandal;Anil Kumar

  • Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.

    Sungsoo Lee;Xiaofeng Lin;Nguyen Hai Nam;Keykavous Parang

  • Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold

    Joanna Bojarska;Adam Mieczkowski;Zyta M. Ziora;Mariusz Skwarczynski

  • Synthesis, Anticancer Activities, and Cellular Uptake Studies of Lipophilic Derivatives of Doxorubicin Succinate

    Bhupender S. Chhikara;Deendayal Mandal;Keykavous Parang

  • 3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities.

    V. Kameshwara Rao;Bhupender S. Chhikara;Amir Nasrolahi Shirazi;Rakesh Tiwari

  • Enhanced Cellular Uptake of Short Polyarginine Peptides through Fatty Acylation and Cyclization

    Donghoon Oh;Amir Nasrolahi Shirazi;Amir Nasrolahi Shirazi;Kevin Northup;Brian Sullivan

  • Cyclic peptide-capped gold nanoparticles as drug delivery systems

    Amir Nasrolahi Shirazi;Dindyal Mandal;Rakesh K. Tiwari;Liangran Guo

  • Synthesis and Antifungal Activities of Myristic Acid Analogs

    Keykavous Parang;Edward E. Knaus;Leonard I. Wiebe;Soroush Sardari

  • Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.

    Asal Fallah-Tafti;Alireza Foroumadi;Rakesh Tiwari;Amir Nasrolahi Shirazi

Frequent Co-Authors

Philip A. Cole
Philip A. Cole Brigham and Women's Hospital
Akhilesh K. Verma
Akhilesh K. Verma University of Delhi
Alireza Foroumadi
Alireza Foroumadi Tehran University of Medical Sciences
Anil Kumar
Anil Kumar Indian Institute of Information Technology Design and Manufacturing Jabalpur
Abdollah Ghasemi Pirbalouti
Abdollah Ghasemi Pirbalouti Islamic Azad University, Tehran
Stevan R. Hubbard
Stevan R. Hubbard New York University
Navindra P. Seeram
Navindra P. Seeram University of Rhode Island
Virinder S. Parmar
Virinder S. Parmar City University of New York
Istvan Toth
Istvan Toth University of Queensland
Solomon H. Snyder
Solomon H. Snyder Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry in the USA opens the door to various interdisciplinary career paths, including those in forensic science and criminal justice. Many professionals combine their chemistry background with specialized studies, such as forensic psychology master's programs, to enhance their expertise in analyzing evidence and understanding behavioral aspects related to crime.

Career opportunities in this field are diverse, and exploring careers in forensics can help you identify options that align with your interests. Whether you're interested in laboratory analysis, crime scene investigation, or legal consulting, having a strong foundation in both science and justice is crucial.

Cost is an important factor to consider when selecting a program. Detailed information on criminal justice degree tuition can help you budget and plan your education effectively. Many online programs offer flexible and affordable options to accommodate working professionals and full-time students alike.

If you're seeking an accessible entry point, the best online criminal justice associate degree programs provide foundational knowledge that can lead to advanced degrees or immediate employment in the field. Combining these programs with a chemistry background broadens your skill set and job prospects.

Best Scientists Citing Keykavous Parang

Trending Scientists

Recently Published Articles